Biorestorative Therapies, Inc. · NASDAQ:BRTX
ALSTODT LANCE reported a 15.50% stake in Biorestorative Therapies, Inc. (Schedule 13D/A)
Event Feb 14, 2025 · Filed Feb 19, 2025
ALSTODT LANCE reported a 15.50% stake in Biorestorative Therapies, Inc., 1,236,809 shares, with active intent on Feb 14, 2025. Filed Feb 19, 2025 (Schedule 13D/A).
- Stake
- 15.50%
- Shares
- 1,236,809
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| ALSTODT LANCE | 15.50% | 1,236,809 |
Source
Related
- Biorestorative Therapies, Inc.
- Alstodt Lance
- Biorestorative Therapies, Inc. shareholders
- Schedule 13G/A · Alta Partners LLC · Aug 3, 2026
- Schedule 13G/A · Auctus Fund, LLC · May 15, 2026
- Schedule 13G/A · Morrison Todd Hale · Feb 23, 2026
- Schedule 13G · Mitchell P. Kopin · Feb 18, 2026
- Schedule 13G/A · Auctus Fund, LLC · Feb 17, 2026